1-butyl-4-vinylpyridine bromide | 1745-93-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 1-butyl-4-vinylpyridine bromide
• 英文别名: 1-Butyl-4-vinyl-pyridinium bromide；1-butyl-4-ethenylpyridin-1-ium;bromide
• CAS: 1745-93-3
• 化学式: Br*C₁₁H₁₆N
• 分子量: 242.159
• InChiKey: MUKNGMSBUDWOSC-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -0.58
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  3.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-乙烯基吡啶 、 正溴丁烷 反应 24.0h， 生成 1-butyl-4-vinylpyridine bromide
  参考文献：
  名称：

  Fluorescent nanoparticles assembled from a poly(ionic liquid) for selective sensing of copper ions

  摘要：

  荧光纳米粒子是通过离子相互作用由聚（离子液体）形成的。该荧光纳米粒子表现出高荧光强度和对紫外光照射的稳定性，可用于铜离子的高灵敏度和选择性荧光传感器。

  DOI：

  10.1039/c0cc03900d

文献信息

• Toner compositions
  申请人：XEROX CORPORATION

  公开号：EP0185509A1

  公开（公告）日：1986-06-25

  A toner composition comprised of resin particles, and pigment particles surface-treated with charge-enhancing additives selected from homopolymers of amine-containing monomers, copolymers containing amine monomers, quaternary ammonium salt compounds, polymeric amines, polymeric quaternary ammonium compounds, telomeric amines and telomeric quaternary ammonium salt compositions, wherein the charge-enhancing additives are associated with, or attached to, the pigment particles.

  一种墨粉组合物，由树脂颗粒和经电荷增强添加剂表面处理的颜料颗粒组成，电荷增强添加剂选自含胺单体的均聚物、含胺单体的共聚物、季铵盐化合物、聚合胺、聚合季铵盐化合物、端聚胺和端聚季铵盐组合物，其中电荷增强添加剂与颜料颗粒相关联或附着在颜料颗粒上。
• Utilization of a multi-character material in a surface coating of an electrosurgical instrument
  申请人：MegaDyne Medical Products, Inc.

  公开号：US20030109865A1

  公开（公告）日：2003-06-12

  Providing a multi-character material as part of a coating of an electrosurgical instrument. The multi-character material includes molecular chains having a hydrophobic characteristic or charged unit that bonds to a metallic substrate and/or a base material coating layer of the tip, and a hydrophilic characteristic that provides desired properties to the coated surface, such as the ability to attract water to assist in cooling and/or lubricating an electrosurgical tip, to create a low shear, sacrificial layer that protects and enhances eschar release characteristics, to supply a radical scavenger or inhibitor that reduces damage at the tip, and/or to deposit factors, such as healing factors, from the tip onto one or more contact surfaces of the patient's body. Optionally, an additional covering layer of a hydrophilic material may be applied over the multi-character material coating layer to increase the desired properties at the coated surface.

  提供一种多特性材料，作为电外科器械涂层的一部分。多特性材料包括具有疏水特性或带电单元的分子链，可与金属基底和/或针尖的基底材料涂层结合，还具有亲水特性，可为涂层表面提供所需的特性，如吸水能力，以帮助冷却和/或润滑电外科手术针尖、形成低剪切力的牺牲层，以保护和增强焦痂释放特性；提供自由基清除剂或抑制剂，以减少针尖的损伤；和/或将因子（如愈合因子）从针尖沉积到患者身体的一个或多个接触面上。可选择在多特性材料涂层层上再覆盖一层亲水性材料，以增加涂层表面所需的特性。
• NOVEL POLYMER BINDER SYSTEMS COMPRISING IONIC LIQUIDS
  申请人：——

  公开号：US20040054041A1

  公开（公告）日：2004-03-18

  The invention relates to mixtures of (meth)acrylate polymers and ionic liquids.

  本发明涉及（甲基）丙烯酸酯聚合物和离子液体的混合物。
• Dosage forms for tamper prone therapeutic agents
  申请人：Soscia Anthony Edward

  公开号：US20080075669A1

  公开（公告）日：2008-03-27

  A dosage form from which a burst release of a drug contained within a tampered dosage form is reduced or retarded by the presence in or on the dosage form of a TPTA (Tamper Prone Therapeutic Agent) trap. If the dosage form has not been tampered with, the TPTA trap does not significantly interfere with the rate of release of the drug from the dosage form. However, if the dosage form has been physically tampered with, the TPTA trap reduces or retards burst release of the drug from the dosage form.
• Enzyme-Channeling Based Electrochemical Biosensors
  申请人：Rishpon Judith

  公开号：US20090061524A1

  公开（公告）日：2009-03-05

  Low-cost, non-toxic and fast immunoassay systems (immunosensors) and uses thereof as analytical and diagnostic tools for detecting an immune response in a subject are disclosed. The systems and methods disclosed are based on recording an electrochemical signal which is generated proportionally to an enzymatic cascade reaction (enzyme-channeling) upon detecting an analyte, and therefore can be used to determine the titer level of an antibody analyte in a liquid sample such as artificial media, serum or blood both qualitatively and quantitatively, in a one-step and separation free immunoassay. Systems and methods based on recording an electrochemical signal which is generated proportionally to an enzymatic cascade reaction (enzyme-channeling) upon detecting an analyte, which utilize a non-toxic secondary substrate such as acetaminophen are also disclosed.